日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19

利用统计免疫保护相关性模型预测中和抗体滴度对单克隆抗体免疫桥接预防COVID-19疗效的影响

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-026-01315-6
Yalcin, Ilker; Hu, Leijun; West, Brandyn; Narayan, Kristin; Holmes, Anna; Wingertzahn, Mark A
单克隆抗体
免疫/内分泌
发表日期：2026
文献求助 收藏

Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)

长效单克隆抗体 Pemivibart 预防 COVID-19 症状的安全性和有效性：3 期随机临床试验 (CANOPY) 的中期结果

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciaf265
Wolfe, Cameron R; Cohen, Jonathan; Mahoney, Kathryn; Holmes, Anna; Betancourt, Natalia; Gupta, Deepali; Tosh, Kazima; Narayan, Kristin; Campanaro, Ed; Katz, Chloe; Phelan, Anne-Marie; Yalcin, Ilker; Wingertzahn, Mark; Hawn, Pamela; Schmidt, Pete; Li, Yong; Popejoy, Myra
单克隆抗体
发表日期：2025
文献求助 收藏

Safety, Pharmacokinetics, Serum Neutralizing Titers, and Immunogenicity of Adintrevimab, a Monoclonal Antibody Targeting SARS-CoV-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Dose-escalation Study in Healthy Adults

针对 SARS-CoV-2 的单克隆抗体 Adintrevimab 的安全性、药代动力学、血清中和滴度和免疫原性：一项在健康成年人中进行的随机、双盲、安慰剂对照、1 期剂量递增研究

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-023-00794-1
Schmidt, Pete; Gong, Jean; Narayan, Kristin; Gupta, Deepali; Engler, Frank; Li, Yong; Copans, Amanda; Campanaro, Ed
单克隆抗体
SARS-CoV-2
免疫/内分泌
发表日期：2023
文献求助 收藏

Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19

预防性使用单克隆抗体Adintrevimab可保护仓鼠和非人灵长类动物免受SARS-CoV-2感染，以预防COVID-19。

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.01353-22
Zumbrun, Elizabeth E; Kaku, Chengzi I; Dillinger, Lukas; Zak, Samantha E; Kuehne, Ana I; Bakken, Russel R; Koehler, Jeffrey W; Delp, Korey L; Stefan, Christopher P; Kumar, Raina; Kugelman, Jeffrey R; Moreau, Alicia M; Zeng, Xiankun; Dye, John M; Herbert, Andrew S; Narayan, Kristin; Walker, Laura M
单克隆抗体
SARS-CoV-2
Primate
炎症/感染
Hamster
Human
发表日期：2023
文献求助 收藏

Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron

Adintrevimab (ADG20) 治疗轻度或中度冠状病毒病 2019 高危门诊患者的疗效和安全性：一项在 Delta 病毒占主导地位和 Omicron 病毒早期出现期间开展的 2/3 期随机、安慰剂对照试验 (STAMP) 的结果

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofad279
Ison, Michael G; Popejoy, Myra; Evgeniev, Nikolay; Tzekova, Maria; Mahoney, Kathryn; Betancourt, Natalia; Li, Yong; Gupta, Deepali; Narayan, Kristin; Hershberger, Ellie; Connolly, Lynn E; Yalcin, Ilker; Das, Anita F; Genge, John; Smith, Michelle; Campanaro, Ed; Hawn, Pamela; Schmidt, Pete
微生物学
发表日期：2023
文献求助 收藏

Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)

单次肌注Adintrevimab预防COVID-19：一项2/3期随机、双盲、安慰剂对照试验（EVADE）的结果

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofad314
Ison, Michael G; Weinstein, Debra F; Dobryanska, Marta; Holmes, Anna; Phelan, Anne-Marie; Li, Yong; Gupta, Deepali; Narayan, Kristin; Tosh, Kazima; Hershberger, Ellie; Connolly, Lynn E; Yalcin, Ilker; Campanaro, Ed; Hawn, Pamela; Schmidt, Pete
发表日期：2023
文献求助 收藏

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study

单克隆抗体VIS410治疗成人单纯性甲型流感感染的安全性和有效性：一项随机、双盲、II期、安慰剂对照研究的结果

期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2018.12.051
Hershberger, Ellie; Sloan, Susan; Narayan, Kristin; Hay, Catherine A; Smith, Patrick; Engler, Frank; Jeeninga, Rienk; Smits, Saskia; Trevejo, Jose; Shriver, Zach; Oldach, David
单克隆抗体
炎症/感染
流感
微生物学
发表日期：2019
文献求助 收藏

Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.

疫苗诱导的 2 级 HIV-1 中和抗体与 CD4 结合位点附近缺乏聚糖的四级表位结合

期刊:PLoS Pathogens
影响因子:4.9
doi:10.1371/journal.ppat.1004932
Crooks Ema T, Tong Tommy, Chakrabarti Bimal, Narayan Kristin, Georgiev Ivelin S, Menis Sergey, Huang Xiaoxing, Kulp Daniel, Osawa Keiko, Muranaka Janelle, Stewart-Jones Guillaume, Destefano Joanne, O'Dell Sijy, LaBranche Celia, Robinson James E, Montefiori David C, McKee Krisha, Du Sean X, Doria-Rose Nicole, Kwong Peter D, Mascola John R, Zhu Ping, Schief William R, Wyatt Richard T, Whalen Robert G, Binley James M
其它
T细胞
发表日期：2015
文献求助 收藏

Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate

用 HIV-1 gp120 对兔子进行初免-加强免疫，可诱导针对原代病毒分离株的强效中和活性。

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0052732
Narayan, Kristin M; Agrawal, Nitish; Du, Sean X; Muranaka, Janelle E; Bauer, Katherine; Leaman, Daniel P; Phung, Pham; Limoli, Kay; Chen, Helen; Boenig, Rebecca I; Wrin, Terri; Zwick, Michael B; Whalen, Robert G
HIV
免疫/内分泌
微生物学
发表日期：2013
文献求助 收藏